Ledipasvir / Sofosbuvir for the Treatment of Chronic Hepatitis C: A Cost-Effectiveness Analysis Across Different Genotype 1 Clinical Subgroups
Value in Health - United Kingdom
doi 10.1016/j.jval.2015.09.1966
Full Text
Open PDFAbstract
Available in full text
Date
November 1, 2015
Authors
Publisher
Elsevier BV